Skip to content

Modified on-site macroscopic evaluation (MOSE) for the quality assessment of pancreatic fine needle aspiration samples and the construction of an AI model to evaluate the quality of samples

Modified on-site macroscopic evaluation (MOSE) for the quality assessment of pancreatic fine needle puncture samples and the construction of an AI model to evaluate the quality of samples

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400080476
Enrollment
Unknown
Registered
2024-01-30
Start date
2024-02-01
Completion date
Unknown
Last updated
2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive disease

Interventions

Gold Standard:Histology based on surgical excision specimens is defined as the gold standard. For patients who have not undergone surgery, the final diagnosis is confirmed by at least 6 months of foll
Index test:Modified MOSE and traditional MOSE estimate the adequacy of FNA samples

Sponsors

The Third People's Hospital of Chengdu
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age = 20 years old; 2. Imaging studies such as CT, MRI, PET-CT, or EUS display pancreatic lesions; 3. EUS-FNA is required for pathological diagnosis

Exclusion criteria

Exclusion criteria: 1: bleeding disorders or use of antiplatelet drugs 2: possible or confirmed pregnancy 3: pathological diagnosis already obtained by other methods 4: anatomical change because of surgery 5: refusal to participate in the study

Design outcomes

Primary

MeasureTime frame
Consistency between modified MOSE and traditional MOSE in estimating the adequacy of FNA samples;

Countries

China

Contacts

Public ContactJing Shan; Zhou Xi

The Third People's Hospital of Chengdu

tulip-sj@163.com+86 156 5885 0832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026